Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data

British Journal of Cancer
Tobias JanowitzHugo Ford

Abstract

Second-line chemotherapy treatment of patients with relapsed gastric and oesophageal cancers in comparison with supportive care (SC) alone has been supported by recent phase 3 clinical trials, but a meta-analysis of patient-level data is lacking. We searched Medline, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Web of Science for phase 3 clinical trials that compared second-line chemotherapy with SC alone for gastric and oesophageal cancers. A meta-analysis of the comprehensive patient-level data from the three identified trials was performed. A total of 410 patients with gastric (n=301), gastroesophageal junction (n=76), or oesophageal (n=33) adenocarcinoma were identified. In all, 154 patients received single-agent docetaxel and 84 patients received single-agent irinotecan, each with SC. SC alone was given to 172 patients. Chemotherapy significantly reduced the risk of death (hazard ratio (HR)=0.63, 95% confidence interval (CI)=0.51-0.77, P<0.0001). This effect was observed for treatment with docetaxel (HR=0.71, 95% CI=0.56-0.89, P=0.003) and irinotecan (HR=0.49, 95% CI=0.36-0.67, P<0.001). Overall survival (OS) benefit was greatest for patients who progressed 3-6 months following first-line chemother...Continue Reading

References

Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Jul 25, 2009·Lancet·Henk H HartgrinkCornelis J H van de Velde
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Anna Dorothea WagnerWolfgang E Fleig
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peter C Thuss-PatiencePeter Reichardt
Feb 4, 2012·The Lancet Oncology·S Yousuf ZafarAmy P Abernethy
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jung Hun KangSe Hoon Park
Aug 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H S KimD Y Zang
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Atsushi OhtsuEric Van Cutsem
Jul 3, 2015·Therapeutic Advances in Gastroenterology·Hugo Ford, Ioannis Gounaris

❮ Previous
Next ❯

Citations

Sep 5, 2017·World Journal of Gastrointestinal Oncology·Michael DavidsonNaureen Starling
May 9, 2019·Journal of Medical Economics·Diego NovickJuan Carlos Velasquez
Feb 23, 2020·Oncotarget·Raquel Carvalho MontenegroSusanne Müller
Jul 6, 2020·Expert Opinion on Biological Therapy·Shun Yamamoto, Ken Kato
Aug 1, 2020·PloS One·Almudena Cotes SanchísAlberto Carmona-Bayonas
Mar 17, 2017·British Journal of Cancer·Yanjing SongLin Chen
Mar 28, 2018·Targeted Oncology·Maria Di BartolomeoFerdinando De Vita
Apr 13, 2019·International Journal of Clinical Oncology·Takahiro IshiiKohei Shitara
Dec 29, 2016·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Valentina FanottoGiuseppe Aprile
Sep 7, 2019·Therapeutic Advances in Medical Oncology·Elizabeth C Smyth, Markus Moehler
May 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Russell D PettyZosia Miedzybrodzka
Jul 2, 2019·Therapeutic Advances in Medical Oncology·Akihito Kawazoe, Kohei Shitara
Aug 12, 2020·Future Oncology·Shun Yamamoto, Ken Kato
Jan 11, 2019·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Akinori SasakiKohei Shitara
Mar 20, 2021·Expert Opinion on Biological Therapy·Hayato MikuniKen Kato
Jun 7, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Patrícia M R PereiraJason S Lewis

❮ Previous
Next ❯

Software Mentioned

SAS
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
H S KimD Y Zang
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Stephen J ClarkeAustralasian Gastro-Intestinal Trials Group
© 2022 Meta ULC. All rights reserved